| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/24/2004 | EP1478740A2 Heteromultimeric tnf ligand family members |
| 11/24/2004 | EP1478736A2 High-level production of amyloid-beta peptides from imr-32 cells |
| 11/24/2004 | EP1478733A2 Cold shock inducible expression and production of heterologous polypeptides |
| 11/24/2004 | EP1478666A2 Dermopharmaceutically and cosmetically active oligopeptides |
| 11/24/2004 | EP1478665A2 Organic compounds having anti-angiogenic activity |
| 11/24/2004 | EP1478663A1 Novel genes functionally related to dyslexia |
| 11/24/2004 | EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 11/24/2004 | EP1478661A2 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 11/24/2004 | EP1478660A2 KAPPA−PVIIA−RELATED CONOTOXINS AS ORGAN PROTECTANTS |
| 11/24/2004 | EP1478659A2 Biologically active peptides |
| 11/24/2004 | EP1478658A2 Molecular linkers suitable for crystallization and structural analysis of molecules of interest, method of using same, and methods of purifying g protein-coupled receptors |
| 11/24/2004 | EP1478657A2 Sequence analysis of the tetravalent rotavirus vaccine |
| 11/24/2004 | EP1478655A2 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 11/24/2004 | EP1478654A2 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |
| 11/24/2004 | EP1478393A2 Anti-pathogen treatements |
| 11/24/2004 | EP1478392A2 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 11/24/2004 | EP1478390A2 Novel complexes for inducing an immune response |
| 11/24/2004 | EP1478388A1 Purification of red blood cells by separation and diafiltration |
| 11/24/2004 | EP1478384A2 Method for increasing the survival of dopamine secreting cells |
| 11/24/2004 | EP1478383A2 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 11/24/2004 | EP1478379A2 Humanized lactoferrin and uses thereof |
| 11/24/2004 | EP1478378A2 Anti-allergic complex molecules |
| 11/24/2004 | EP1478354A2 Use of tgf-beta antagonists to treat or to prevent chronic transplant rejection |
| 11/24/2004 | EP1478328A2 Bioactive keratin peptides |
| 11/24/2004 | EP1478305A2 Therapeutic polyesters and polyamides |
| 11/24/2004 | EP1478236A2 Targeted retrograde gene delivery to motor neurons |
| 11/24/2004 | EP1478233A2 Method for administering glp-1 molecules |
| 11/24/2004 | EP1450846A4 Self-assembling polymers, and materials fabricated therefrom |
| 11/24/2004 | EP1434790A4 Calcium-influx inhibitory factor and method of isolation thereof |
| 11/24/2004 | EP1430082A4 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 11/24/2004 | EP1392859A4 Isolating cells expressing secreted proteins |
| 11/24/2004 | EP1390503A4 Novel nucleic acid molecules |
| 11/24/2004 | EP1381625B1 Mutants of green fluorescent protein |
| 11/24/2004 | EP1303539B1 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 11/24/2004 | EP1285000B1 Adnf mixtures for enhancing learning and memory |
| 11/24/2004 | EP1238279B1 Helicobacter pylori antigens in blood |
| 11/24/2004 | EP1233984B1 PROCESS FOR PRODUCING WASP POISON ALLERGENS WITH REDUCED IgE-REACTIVITY |
| 11/24/2004 | EP1218531B1 Method for extracting bacterio-rhodopsin |
| 11/24/2004 | EP1214340B1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 11/24/2004 | EP1200470B1 Globular assembly of amyloid beta protein and uses thereof |
| 11/24/2004 | EP1171587B1 Peptide from antigen muc-1 for triggering an immune response to tumor cells |
| 11/24/2004 | EP1161545B1 Methods of using viral replicase |
| 11/24/2004 | EP1155127A4 Method of modifying plant morphology, biochemistry and physiology ii |
| 11/24/2004 | EP1140023B1 Integrative protein-dna cochleate formulations and methods for transforming cells |
| 11/24/2004 | EP1115737A4 Novel interferon stimulated and repressed genes |
| 11/24/2004 | EP1009827B1 Chimeric binding peptide library screening method |
| 11/24/2004 | EP1009754A4 Presenilin-1 gene promoter |
| 11/24/2004 | EP1003840A4 Synthetic genes for plant gums |
| 11/24/2004 | EP0998493B1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 11/24/2004 | EP0981546A4 Protein smi on hematopoietic stem cells |
| 11/24/2004 | EP0979237B1 Method for removing viruses from protein solutions by nanofiltration |
| 11/24/2004 | EP0971738B1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants |
| 11/24/2004 | EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis |
| 11/24/2004 | EP0944392A4 Process for separating alpha-1-proteinase inhibitor from cohn fraction iv 1? +iv 4? paste |
| 11/24/2004 | EP0914333B1 Peptide derivatives |
| 11/24/2004 | EP0912157B1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 11/24/2004 | EP0856157B1 Tumour-specific p450 protein |
| 11/24/2004 | EP0826064B1 Low oxygen affinity mutant hemoglobin |
| 11/24/2004 | EP0783317B1 Mimetics of senescent cell derived inhibitors of dna synthesis |
| 11/24/2004 | EP0745129B1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 11/24/2004 | EP0717752B1 Therapeutic compounds |
| 11/24/2004 | EP0656012B1 T cell epitopes of ryegrass pollen allergen |
| 11/24/2004 | EP0551438B1 Surface expression libraries of randomized peptides |
| 11/24/2004 | CN1549862A Transgenic plants expressing cobalamin binding proteins |
| 11/24/2004 | CN1549861A Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 11/24/2004 | CN1549859A Fluorescent proteins |
| 11/24/2004 | CN1549858A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 11/24/2004 | CN1549857A Testicular carnitine transporter and its gene |
| 11/24/2004 | CN1549826A Compositions and methods of treating diabetes |
| 11/24/2004 | CN1549825A Purification process |
| 11/24/2004 | CN1549824A Peptidic compounds selectively binding to p-selectin |
| 11/24/2004 | CN1549823A Production of high molecular mass lectins |
| 11/24/2004 | CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 11/24/2004 | CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 11/24/2004 | CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity. |
| 11/24/2004 | CN1549722A Anti-cancer and wound healing compounds |
| 11/24/2004 | CN1548539A Method, special plasmid and function nucleotide segment for obtaining male sterile wheat |
| 11/24/2004 | CN1548525A Recombinant yeast strain and IFN alpha-la interferon purifying process |
| 11/24/2004 | CN1548459A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 11/24/2004 | CN1548458A Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 11/24/2004 | CN1548457A Tumor antigen protein and tumor antigen peptide |
| 11/24/2004 | CN1548456A Specific liver gene and protein related to liver carcinoma differentiation and progression |
| 11/24/2004 | CN1548455A Tumor antigen protein and tumor antigen peptide |
| 11/24/2004 | CN1548454A Tumor suppressor protein and its application |
| 11/24/2004 | CN1548453A Frigostable correlative transcriptive factor of rice and its coding gene and application |
| 11/24/2004 | CN1548452A One kind of membrane protein of SARS coronavirus and its encoding gene and application |
| 11/24/2004 | CN1548149A Application of recombinant alpha-interferon in preparing medicine for preventing and treating respiratory system infection |
| 11/24/2004 | CN1177052C Human growth factor variation spliceosome protein and coding sequence thereof |
| 11/24/2004 | CN1177051C Recombinant thymin alpha-1 and its prepn |
| 11/24/2004 | CN1177050C Coding polynucleotide of human protein with function of suppressing cancer cell growth |
| 11/24/2004 | CN1177049C Coding polynucleotide of human protein with function of suppressing cancer cell growth |
| 11/24/2004 | CN1177048C Coding polynucleotide of human protein with function of suppressing cancer cell growth |
| 11/24/2004 | CN1177047C Coding polynucleotide of human protein with cancer suppressing function |
| 11/24/2004 | CN1177046C Enhanced virus-mediated DNA transfer |
| 11/24/2004 | CN1177042C Recombinant adenovirus of coexpression human P53 gene and human cytokine gene and its preparation method and application |
| 11/24/2004 | CN1176947C Parathyroid hormone analogues for the treatment of osteoporosis |
| 11/24/2004 | CN1176946C New-type alpha-interferon |
| 11/24/2004 | CN1176945C Plasmodium fused antigen and its preparing process usage |
| 11/24/2004 | CN1176944C Antibacterial polypeptide separated from biological living body |
| 11/24/2004 | CN1176943C Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method |